Inhibitory Effects of Successive Solvant
Extracts of Barleria gibsoni Dalz. on the Proliferation of MDA MB 4355 (Human Breast Cancer) and Hep G2 (Liver Cancer Cell line)
Firoj A. Tamboli*,
Harinath N. More
Department of Pharmacognosy,
Bharati Vidyapeeth College of
Pharmacy, Near Chitranagari, Kolhapur -416013
*Corresponding Author E-mail: firojtamboli143@gmail.com,
firoj.tamboli@bharatividyapeeth.edu
ABSTRACT:
The objective of this study
was to investigate the ant proliferative
activity of the successive solvent extract of leaves of plant of Barleria gibsoni Dalz. against MDA MB 4355 (Human breast cancer) and Hep G2 (Liver cancer cell line). 5 fluorouracil
was given as reference drug. The leaves of plant were dried in shade and they were
powdered and extracted with different solvents extract like petroleum ether, chloroform,
acetone, ethyl acetate, ethanol. The preliminary phytochemical tests were done. Pet ether, chloroform extract
of leaves showed that significant ant proliferative effects were obtained against
MDA MB 4355 (Human breast cancer) by SRB assay method and ethanol extract of leaves
showed moderate activity against Hep G2 (Liver cancer
cell line) by MTT assay method due to presence of phytoconstituents
present in the plant.
KEY WORDS: Barleria gibsoni Dalz. ant proliferative activity,
5-fluorouracil, MDA MB 4355 (Human breast cancer) and Hep G2 (Liver cancer cell line).
INTRODUCTION:
Barleria gibsoni Dalz. (Acanthaceae) is widely distributed
throughout Africa, India, Sri Lanka and tropical Asia. It is commonly known as Neel
Koranti, the juice of the leaf is used in cataract, ulcer
and fever. The dried bark is used in cough treatment and the leaves chewed to relieve
toothache. The paste of the root is applied to disperse boils and glandular swellings1.
It exhibits several medicinal properties. Leaves are also used by some tribal communities
for the treatment of piles and to control irritation. Plant is also used in stiffness
of limbs, enlargement of scrotum and sciatica2-5. In recent years multiple
drug resistance has developed due to indiscriminate use of existing antimicrobial
drugs in the treatment of infectious diseases 6.
MATERIAL AND METHOD:
Plant
Material:
The fresh leaves of the Barleria gibsoni were collected during the month of May-June
when flowering, from Satara region, Maharashtra, India.
The plant was authenticated by Botanical survey of India, Pune,
Maharashtra, India.
A voucher specimen (BSI/WRC/Tech/2013/FAT 01 dated 27th December,
2013) has been deposited at the herbarium of same place for further reference.
Preparation of Extracts:
The leaves of Barleria gibsoni were
washed with water, air- dried at room temperature and then reduced to coarse powder.
A powdered leaves (100g) was successively extracted with petroleum ether, chloroform,
acetone, ethyl acetate and ethanol using Soxhlet apparatus.
The extracts were filtered and the filtrates were concentrated under reduced pressure
to obtain the extracts as solid residues.
Table.1:
Phytochemical screening of Barleria gibsoni Dalz.
Secondary
Metabolites |
Petroleum
ether |
Chloroform |
Acetone
|
Ethyl
acetate |
Ethanol |
Alkaloids |
+ |
- |
+ |
- |
+ |
Flavonoids |
- |
+ |
+ |
+ |
+ |
Steroids |
- |
- |
_ |
- |
+ |
Saponins |
- |
- |
+ |
+ |
+ |
Phytochemical test:
Preliminary phytochemical analysis of the extract was performed by simple
chemical tests.7,8
Cancer Cell Cultures:
Hep G2, (liver cancer cell line) MDA MB 4355 (Human breast
cancer) cell lines were purchased from NCCS, Pune, India.
All cell lines were grown and maintained in suitable (RPMI-15-media and were grown
and subculture in medium supplemented with 10% fetal bovine serum, 1% L-Glutamine.1%
penicillin- streptomycin-amphotericine-B antibiotic solution.
All cells were trypsinated using try sin-EDTA solution
and seeded in96 well plates.
Ant proliferative assay of extract on MDA MB 4355 (Human
breast cancer) 9,10:-
The MDA MB 4355 (Human breast cancer) was maintained in
L-15-media supplemented with 10 % fetal bovine serum. The cells were plated at a
density of 1 × 105 cells per well in a 96-well plate, and cultured for 24 h at 37 °C.
The cells were subsequently exposed to 10, 50 µg/ml. The plates were incubated
for 24 h, Test compounds were prepared in PBS and Controls were performed with medium
alone. Ant proliferative activity was assessed by performing the Sulphorhodamine B (SRB) assay. Cells were fixed by adding 25
µL of ice-cold 50% trichloroacetic acid on top of the
growth medium and the plates were incubated at 4 °C for 1 h, after which plates
were washed to remove traces of medium, drug and serum. SRB stain (50 µL; 0.4% in
1% acetic acid) (Sigma) was added to each well and left in contact with the cells
for 30 min after which they were washed with 1% acetic acid, rinsing 4 times until
only dye adhering to the cells was left. The plates were then dried and 100 µL of
10 mM Tris buffer (Sigma) added
to each well to solubilise the dye. The plates were shaken
gently for 5 min and absorbance was read at 550 nm using a micro plate reader. Lastly
percent cytotoxicity of the compounds was calculated by
using following formula.
Percent Cytotoxicity =
Reading of control - Reading
of treated cells X100
Reading of control
Antiproliferative assay of extract on Hep G2 (Liver
cancer cell line) 11,12
The Hep G2 cell line was maintained
in MEM medium
supplemented with 10 % fetal
bovine serum. The cells were plated at a density of 1 × 105 cells per
well in a 96-well plate, and cultured for 24 h at 37°C. The cells were subsequently exposed to 10, 50
µg/ml. The plates were incubated for 48
h, and
cell proliferation was measured
by adding 10 µL of MTT
(thiazolyl blue tetrazolium bromide)
dye (5 mg ml-1 in phosphate-buffered saline)
per well. The plates were incubated for a further 4 h at 37°C in a humidified chamber
containing 5% CO2. Formazan crystals formed
due to reduction of dye by viable cells in each well were dissolved in 200 µl DMSO,
and absorbance was read at 490 nm. The results were compared with the standard drug
inhibitors 5- flurouracil. (20µg/ml) percent inhibition
was calculated as above formula.
RESULTS:
The
preliminary Phytochemical analysis revealed the presence
of alkaloids, flavonoids saponins
and steroids
Table . 2: Antiproliferative
activity of Successive solvent Extracts of Barleria gibsoni Dalz. against MDA MB 4355 (Human
breast cancer) by SRB assay
Successive solvent Extracts of leaves |
% Inhibition (10 µg/ml) |
% Inhibition (50 µg/ml) |
Pet ether |
61.66 |
61.66 |
Chloroform |
60.00 |
63.33 |
Acetone |
< 50 |
31.66 |
Ethyl acetate |
45.00 |
40.00 |
Ethanol |
23.33 |
26.66 |
5- flurouracil (50
µg/ml) |
55.00 |
64.33 |
As shown in Table. 2 the successive
solvent extract displayed inhibition activities against breast human cancer cell
lines. Notably, petroleum ether and chloroform extracts exhibited significant inhibitory
activities against MDA MB 4355 cell lines compared to the positive control 5- fluorouracil.
Remaining extracts showed moderate inhibitory activities against MDA MB 4355 cell
lines.
Table . 3: Antiproliferative
activity of Successive solvent Extracts of Barleria gibsoni Dalz. against Hep G2 cell line (Human
liver cancer) by MTT assay
Successive solvent Extracts of leaves |
% Inhibition (10 µg/ml) |
% Inhibition (50 µg/ml) |
Petroleum ether |
21.07 |
21.53 |
Chloroform |
>100 |
>100 |
Acetone |
49.70 |
>100 |
Ethyl acetate |
30.72 |
23.96 |
Ethanol |
25.14 |
60.86 |
5- flurouracil (50 µg/ml) |
64.33 |
80.43 |
As shown in Table.3, the successive
solvent extract displayed inhibition activities against liver human cancer cell
lines. Notably, ethanol extract of leaves exhibited moderate inhibitory activities
against Hep G2 cell lines compared to the positive control
5- fluorouracil.
DISCUSSION:
From
the present study it can be said that ethanol extract of leaves of Barleria gibsoni has
antiproliferative activity against Hep G2 cell line by MTT assay method and pet ether and chloroform
extract of leaves of Barleria gibsoni has antiproliferative
activity against MDA MB 4355 breast cancer cell line by SRB assay method due to
presence of phytoconstituents present in the plant. It
is need to explore the isolation, characterization and development of drug which
could be help to hopeful treatment in cancer disease.
REFERENCES:
1.
Gupta R, Pramod K, Dixit V., Dobhal M. Antifertility studies of
the root extract of the Barleria prionitis Linn in male albino rats with special reference
to testicular cell population dynamics. Journal of ethnopharmacol.
70; 2000: 111–117.
2.
Chopra RN, Nayar SL, Chopra IC. Glossary of Indian
medicinal plants. New Delhi: CSIR; pp 33–34,
1956.
3.
Ambasta
SP. The useful plants of India. New Delhi: CSIR; 1986.
4.
Bhalla NP, Sahu TR, Mishra GP, Dakwala RN. J Econ Taxon Bot. 3: 23, 1992.
5.
Jain SK, Defillips RA.
Medicinal plants of India. New Delhi: CSIR, 1991.
6.
Service RF. Antibiotics that resist resistance. Science, 270; 1992: 724-727.
7.
Harbone,J.P., Phytochemical methods, a guide to modern technique
of plant analysis (chapmann and hall, London),.1-271; 1973
8.
Mukaherjee PK, Quality
control of herbal drugs (an approach to evaluation of botanicals),Business Horizon’s, New Delhi pp. 380-421; 2002.
9.
Potchanapond Graidist, Mananya Martla and Yaowapa Sukpondma, Cytotoxic Activity of Piper
cubeba Extract in Breast Cancer Cell Lines, Nutrients
7; 2015: 2707-2718.
10. Filip Grbovic,
Milan S.Stankovic, Milena Curcic, Natasa Dordevic, Dragana Seklic, Marina Topuzovic and Snezana Markovic, In Vitro Cytotoxic Activity of Origanum vulgare L. on HCT-116 and MDA-MB-231 Cell Lines, Plants 2;2013:
371-378
11. Ray S, Murmu N, Adhikari J, Bhattacharyya
S, Adhikari S, Banerjee S., Inhibition of Hep G2 hepatic
cancer cell growth and CCl₄ induced liver cytotoxicity
in Swiss albino mice by Mahua extract. J Environ Pathol Toxicol Oncol. 33(4); 2014:
295-314.
12. Ali M. Mahmoud
and Hany A. EL-shemy, Cytotoxic Profiling of Some Compounds of Natural Origin against
HepG2 Liver Cancer Cell Line in-vitro. Journal of Arid Land Studies, 22-1; 2012:
191 -194.
Received on 02.12.2015 Accepted
on 20.12.2015
© Asian Pharma Press All Right
Reserved
Asian J. Pharm. Res. 5(4): October- December, 2015; Page 183-185
DOI: 10.5958/2231-5691.2015.00028.3